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Lack of involvement of known oncogenic DNA viruses in
Epstein-Barr virus-negative Hodgkin's disease
AA Armstrong, L Shield, A Gallagher and RF Jarrett
LRF Virus Centre, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK
Summary Epstein-Barr virus (EBV) is associated with around one-third of cases, but young adult cases are rarely EBV associated. In this
study, known oncogenic DNA viruses, including human adenoviruses, papovaviruses and the human herpesviruses-6 (HHV-6) and -8 (HHV-
8) were not detected in Hodgkin's disease lesions. These results suggest that an as yet unidentified infectious agent is involved in the
pathogenesis of non-EBV-associated Hodgkin's disease.
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There is substantial evidence linking Hodgkin's disease (HD) with
the B-lymphotropic herpesvirus Epstein-Barr virus (EBV).
Molecular studies have detected EBV genomes in HD biopsies,
and the EBV LMP-1 protein and EBER RNAs have been localized
to the Reed-Stemnberg (RS) cells, the putative malignant cells of
HD (Weiss et al, 1987, 1991; Herbst et al, 1991; Armstrong et al,
1992).
The distribution of EBV-associated cases is not random. Cases
ofmixed cellularity HD (HDMC) are more likely to be EBV posi-
tive than nodular sclerosis (HDNS) cases (Pallesen et al, 1991;
Glaser et al, 1997). Our data have shown that EBV association
rates in HD vary with age at diagnosis; paediatric and older adult
cases are more likely to be positive than young adult cases, partic-
ularly young adult HDNS cases (Jarrett et al, 1991, 1996). These
results suggest that HD can be divided into three distinct clinical
entities and provide biological support for the multiple aetiology
hypothesis proposed by MacMahon (1966). It is in the young adult
age group that there is the most epidemiological evidence for an
infectious agent; we suggest that this group of cases represents a
distinct disease entity and that an infectious agent other than EBV
is involved in disease pathogenesis.
There are many seroepidemiological studies investigating the
relationship between other viruses and HD, but few molecular
studies. Serological studies have found no consistent association
between herpes simplex virus, varicella zoster virus, cyto-
megalovirus (CMV), human herpesvirus-7 (HHV-7), rubella,
measles and parainfluenza virus (Langenhuysen et al, 1974; Evans
et al, 1978; Evans and Gutensohn, 1984; Clark et al, manuscript in
preparation). However, elevated antibody titres to human
herpesvirus-6 (HHV-6) have been found in HD (Ablashi et al,
1988; Biberfeld et al, 1988; Clark et al, 1990), furthermore anti-
body titres are higher in younger than in older adults and in EBV-
negative as opposed to EBV-associated cases (Clark et al, 1990,
manuscript in preparation). Despite these findings we have failed
to find HHV-6 genomes in 35 cases ofHD examined by Southern
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blot analysis (Gledhill et al, 1991). HHV-6 has been detected by
others in a very small minority of cases but there is no evidence
that HHV-6 is present in RS cells (Torelli et al, 1991; khan et al,
1993; Valente et al, 1996). Molecular studies have excluded direct
involvement by CMV, and a recent study also failed to find
evidence ofHHV-7 genomes in HD (Khan et al, 1993; our unpub-
lished data with Z Bememan).
In the present study, we examined the possibility that human
herpesvirus-8 (HHV-8), the newest member of the herpesvirus
family, is present in HD. This virus is associated with Kaposi's
sarcoma and has also been detected in primary effusion
lymphomas and multicentric Castleman's disease (Chang et al,
1994; Cesarman et al, 1995; Otsuki et al, 1996). In addition, we
investigated whether other DNA tumour viruses, including adeno-
viruses and papovaviruses, were involved in HD. Although adeno-
viruses and polyomaviruses have not been directly associated
with any malignancies in humans, the EIA gene of adenovirus
(Ruley, 1983), SV40 large T antigen (Colby and Shenk, 1982) and
polyomavirus (including LPV) (Takemoto et al, 1982) have all
been shown to have transforming ability in vitro and have the
ability to cause tumours in experimental animals (Brady and
Salzman, 1986). SV40 primarily infects non-human primates, but
infection ofhumans has been documented and an association with
mesothelioma described (Lednicky et al, 1995; Carbone et al,
1996; Pepper et al, 1996).
MATERIALS AND METHODS
Two series of HD cases were examined; the first had been exten-
sively characterized in the past but samples were not considered
suitable for polymerase chain reaction (PCR) studies. Both series
comprised EBV-associated and -non-associated cases as we wished
to determine the relationship between EBV positivity and the
presence ofother viruses.
The first series, comprising 26 cases ofclassical HD, was exam-
ined for the presence of adenovirus types 5 and 12, HHV-6, SV40
and LPV using Southern blot hybridization. Fourteen of these
cases had been analysed previously using an HHV-6 probe and, in
this study, the remaining 12 were analysed (Gledhill et al, 1991).
The breakdown ofthis group by histological subtype, age, sex and
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Table 1 Source of probes for Southern blot study
Virus Clone Reference
Human adenovirus type 5 EIA gene pLal Dery et al (1987)
Human adenovirus type 12 EIA gene pASC10.3 Byrd et al (1982)
SV40 Supercoiled DNA, strain 776 Life Technologies, Paisley, UK
LPV pL6 Pawlita et al (1985)
Human herpesvirus 6 pZVH14 Josephs et al (1986)
SV40, simian virus 40; LPV, lymphotropic papovavirus.
EBV association was as follows: ten cases of HDNS, 15 cases of
HDMC, one case of lymphocyte-depleted HD, HDLD; age range
6-82 years; male-female ratio 16:10; and 13 cases were EBV
associated.
The probes used in the Southern blot study are described in
Table 1. Placental DNA was used as a negative control. Positive
controls included plasmid or viral DNA diluted to a level equiva-
lent to a single-copy gene. In order to test the integrity ofthe DNA
under analysis, all Southern blots were hybridized to the T-cell
receptor n-chain gene C91 3 (Gledhill et al, 1990).
In the second series of 26 classical HD cases (20 cases of
HDNS, four cases of HDMC, two cases of NOS; age range 8-86
years; M/F 14:12), HHV-8 status was determined using a PCR
strategy. Six of 18 ofthese cases were EBV associated; EBV status
was not available for eight cases.
HHV-8 PCR was performed with 1 gg of genomic DNA using
primers specific for HHV-8 sequences (KS330233) as described by
Chang et al (1994). PCR products were hybridized with a radio-
labelled internal oligonucleotide probe. Cloned PCR product was
used as a positive control.
RESULTS
There was no evidence for infection by adenovirus types 5 or 12,
SV40, LPV, HHV-6 or HHV-8 in any ofthe cases examined. In all
assays, the integrity of the DNA samples under analysis was
confirmed, and positive controls gave clear positive signals.
DISCUSSION
Epidemiological evidence suggests that an infectious agent is
involved in the aetiology of HD. EBV has been associated with a
proportion of HD cases but is conspicuously lacking in young
adult cases. It would therefore appear likely that another agent is
involved in this group of cases. In this study, we failed to detect
adenovirus types 5 or 12, SV40, LPV, HHV-6 or HHV-8 in HD
lesions. Previous studies from our group have also failed to find
evidence of HHV-7 or defective EBV genomes in HD. We there-
fore believe that another, as yet unknown, virus is involved in the
development ofEBV-negative cases of HD.
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